Cargando…

Understanding patient and physician perceptions of benign prostatic hyperplasia in Asia Pacific, Latin America and the Commonwealth of Independent States: the Prostate Research on Behaviour and Education (PROBE) II survey

AIM: To assess attitudes and beliefs towards benign prostatic hyperplasia (BPH)/ lower urinary tract symptoms (LUTS) and its treatment among patients and physicians in Latin America, Asia Pacific and the Commonwealth of Independent States (CIS). METHODS: Cross‐sectional, quantitative study conducted...

Descripción completa

Detalles Bibliográficos
Autores principales: Ertel, Phillip, Adalig, Burkay, Demircan, Ipek, Lartey, Belinda, Manyak, Michael J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5129547/
https://www.ncbi.nlm.nih.gov/pubmed/27774780
http://dx.doi.org/10.1111/ijcp.12879
_version_ 1782470607800107008
author Ertel, Phillip
Adalig, Burkay
Demircan, Ipek
Lartey, Belinda
Manyak, Michael J
author_facet Ertel, Phillip
Adalig, Burkay
Demircan, Ipek
Lartey, Belinda
Manyak, Michael J
author_sort Ertel, Phillip
collection PubMed
description AIM: To assess attitudes and beliefs towards benign prostatic hyperplasia (BPH)/ lower urinary tract symptoms (LUTS) and its treatment among patients and physicians in Latin America, Asia Pacific and the Commonwealth of Independent States (CIS). METHODS: Cross‐sectional, quantitative study conducted between December 2014 and September 2015. Separate questionnaires were administered to BPH/LUTS patients receiving drug treatment for their condition and to practising physicians who treat patients with BPH/LUTS. RESULTS: In total, 1094 patients and 202 physicians completed a questionnaire. Most patients (61%) felt very/fairly well informed about BPH/LUTS, and 60% of physicians perceived patients to be very/somewhat informed. Overall, 70% of physicians felt that it would be valuable to raise awareness of BPH/LUTS and encourage men to consult a physician. The first symptoms most commonly noticed by patients were need to urinate more frequently, slower/weaker stream and nocturia. At first consultation, 71% of patients recalled providing a urine sample, 57% having a blood test for prostate‐specific antigen and 56% a digital rectal examination being performed. Over two thirds of patients (69%) were satisfied with their current medication; highest satisfaction rates (among both patients and physicians) were reported for alpha blockers and 5ARIs, either as monotherapies or used in combination. Patients were prepared to wait longer for symptom relief in order to have a reduced risk of surgery. Most physicians (90%) thought that at least some patients believe BPH/LUTS to be a progressive condition. Most physicians thought that patients were very/fairly concerned about BPH surgery (92%) and acute urinary retention (72%); 52% of physicians thought treatment adherence was “extremely” important. CONCLUSIONS: This study provides valuable insights into the attitudes and beliefs of patients and physicians in Asia Pacific, Latin America and CIS about BPH/LUTS and its management. It also highlights areas of discordance between patient/physician perceptions and beliefs about BPH/LUTS, and potential areas of focus to improve the experience of affected patients.
format Online
Article
Text
id pubmed-5129547
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-51295472016-11-30 Understanding patient and physician perceptions of benign prostatic hyperplasia in Asia Pacific, Latin America and the Commonwealth of Independent States: the Prostate Research on Behaviour and Education (PROBE) II survey Ertel, Phillip Adalig, Burkay Demircan, Ipek Lartey, Belinda Manyak, Michael J Int J Clin Pract Urology AIM: To assess attitudes and beliefs towards benign prostatic hyperplasia (BPH)/ lower urinary tract symptoms (LUTS) and its treatment among patients and physicians in Latin America, Asia Pacific and the Commonwealth of Independent States (CIS). METHODS: Cross‐sectional, quantitative study conducted between December 2014 and September 2015. Separate questionnaires were administered to BPH/LUTS patients receiving drug treatment for their condition and to practising physicians who treat patients with BPH/LUTS. RESULTS: In total, 1094 patients and 202 physicians completed a questionnaire. Most patients (61%) felt very/fairly well informed about BPH/LUTS, and 60% of physicians perceived patients to be very/somewhat informed. Overall, 70% of physicians felt that it would be valuable to raise awareness of BPH/LUTS and encourage men to consult a physician. The first symptoms most commonly noticed by patients were need to urinate more frequently, slower/weaker stream and nocturia. At first consultation, 71% of patients recalled providing a urine sample, 57% having a blood test for prostate‐specific antigen and 56% a digital rectal examination being performed. Over two thirds of patients (69%) were satisfied with their current medication; highest satisfaction rates (among both patients and physicians) were reported for alpha blockers and 5ARIs, either as monotherapies or used in combination. Patients were prepared to wait longer for symptom relief in order to have a reduced risk of surgery. Most physicians (90%) thought that at least some patients believe BPH/LUTS to be a progressive condition. Most physicians thought that patients were very/fairly concerned about BPH surgery (92%) and acute urinary retention (72%); 52% of physicians thought treatment adherence was “extremely” important. CONCLUSIONS: This study provides valuable insights into the attitudes and beliefs of patients and physicians in Asia Pacific, Latin America and CIS about BPH/LUTS and its management. It also highlights areas of discordance between patient/physician perceptions and beliefs about BPH/LUTS, and potential areas of focus to improve the experience of affected patients. John Wiley and Sons Inc. 2016-10-23 2016-10 /pmc/articles/PMC5129547/ /pubmed/27774780 http://dx.doi.org/10.1111/ijcp.12879 Text en © 2016 GlaxoSmithKline. International Journal of Clinical Practice Published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial (http://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Urology
Ertel, Phillip
Adalig, Burkay
Demircan, Ipek
Lartey, Belinda
Manyak, Michael J
Understanding patient and physician perceptions of benign prostatic hyperplasia in Asia Pacific, Latin America and the Commonwealth of Independent States: the Prostate Research on Behaviour and Education (PROBE) II survey
title Understanding patient and physician perceptions of benign prostatic hyperplasia in Asia Pacific, Latin America and the Commonwealth of Independent States: the Prostate Research on Behaviour and Education (PROBE) II survey
title_full Understanding patient and physician perceptions of benign prostatic hyperplasia in Asia Pacific, Latin America and the Commonwealth of Independent States: the Prostate Research on Behaviour and Education (PROBE) II survey
title_fullStr Understanding patient and physician perceptions of benign prostatic hyperplasia in Asia Pacific, Latin America and the Commonwealth of Independent States: the Prostate Research on Behaviour and Education (PROBE) II survey
title_full_unstemmed Understanding patient and physician perceptions of benign prostatic hyperplasia in Asia Pacific, Latin America and the Commonwealth of Independent States: the Prostate Research on Behaviour and Education (PROBE) II survey
title_short Understanding patient and physician perceptions of benign prostatic hyperplasia in Asia Pacific, Latin America and the Commonwealth of Independent States: the Prostate Research on Behaviour and Education (PROBE) II survey
title_sort understanding patient and physician perceptions of benign prostatic hyperplasia in asia pacific, latin america and the commonwealth of independent states: the prostate research on behaviour and education (probe) ii survey
topic Urology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5129547/
https://www.ncbi.nlm.nih.gov/pubmed/27774780
http://dx.doi.org/10.1111/ijcp.12879
work_keys_str_mv AT ertelphillip understandingpatientandphysicianperceptionsofbenignprostatichyperplasiainasiapacificlatinamericaandthecommonwealthofindependentstatestheprostateresearchonbehaviourandeducationprobeiisurvey
AT adaligburkay understandingpatientandphysicianperceptionsofbenignprostatichyperplasiainasiapacificlatinamericaandthecommonwealthofindependentstatestheprostateresearchonbehaviourandeducationprobeiisurvey
AT demircanipek understandingpatientandphysicianperceptionsofbenignprostatichyperplasiainasiapacificlatinamericaandthecommonwealthofindependentstatestheprostateresearchonbehaviourandeducationprobeiisurvey
AT larteybelinda understandingpatientandphysicianperceptionsofbenignprostatichyperplasiainasiapacificlatinamericaandthecommonwealthofindependentstatestheprostateresearchonbehaviourandeducationprobeiisurvey
AT manyakmichaelj understandingpatientandphysicianperceptionsofbenignprostatichyperplasiainasiapacificlatinamericaandthecommonwealthofindependentstatestheprostateresearchonbehaviourandeducationprobeiisurvey